FULC
Fulcrum Therapeutics
$3.73
+$0.01 (+0.27%)Jul 27, 2026
Key metrics
The numbers that frame FULC today
- Market cap
- $248.54M
- P/E (TTM)
- -3.3
- EV / FCF
- -3.2
- ROIC
- -38.2%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $2.91
- 52wk High
- $15.74
Growth
Revenue and earnings trend for FULC
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about FULC
Is Fulcrum Therapeutics a good buy?
No. Fulcrum Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Fulcrum Therapeutics is selling at a very high price.
What is the market capitalization of FULC?
Fulcrum Therapeutics's market capitalization is $248.54M.
What is the P/E ratio for FULC stock?
Fulcrum Therapeutics's current P/E ratio is -3.3.
What is the 52-week high for FULC stock?
The 52-week high for Fulcrum Therapeutics is $15.74. The current close of $3.73 is 76.3% below that high.
What is the 52-week low for FULC stock?
The 52-week low for Fulcrum Therapeutics is $2.91. The current close of $3.73 is 28.2% above that low.
Does FULC stock pay dividends?
Fulcrum Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for FULC?
Fulcrum Therapeutics's Debt / Equity ratio is 0.02.